NCT00895739 2013-08-12Alemtuzumab and Low-Dose Cyclosporine in Treating Patients With Severe Aplastic Anemia or Acquired Marrow FailureNational Cancer Institute (NCI)Phase 2 Unknown50 enrolled
NCT00315419 2010-04-21Identifying Characteristics of Bone Marrow Failure SyndromesOffice of Rare Diseases (ORD)Unknown450 enrolled